These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2295593)

  • 1. Methadone and edema.
    Macfadden W; Maany I; Dhopesh V; Woody G
    J Clin Psychiatry; 1990 Jan; 51(1):36-7. PubMed ID: 2295593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Life-threatening, recurrent arrhythmia in patients on high-dose methadone treatment: torsade de pointes].
    Al-Shakarshi JS; Bent-Hansen L; Jensen GB
    Ugeskr Laeger; 2004 Aug; 166(36):3104-5. PubMed ID: 15387312
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone and the QT interval: relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone.
    Skjervold B; Bathen J; Spigset O
    J Clin Psychopharmacol; 2006 Dec; 26(6):687-9. PubMed ID: 17110841
    [No Abstract]   [Full Text] [Related]  

  • 5. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dangers of intravenous use of peroral methadone solutions].
    Shilo L; Liebermann N; Solomon G; Shenkman L
    Harefuah; 1986 Sep; 111(5-6):126-7. PubMed ID: 3804060
    [No Abstract]   [Full Text] [Related]  

  • 7. Driving capacity of patients treated with methadone and slow-release oral morphine.
    Giacomuzzi SM; Ertl M; Vigl A; Riemer Y; Günther V; Kopp M; Pilsz W; Haaser W
    Addiction; 2005 Jul; 100(7):1027. PubMed ID: 15955021
    [No Abstract]   [Full Text] [Related]  

  • 8. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 10. Methadone.
    Wodak AD; Monheit BM
    Med J Aust; 1990 Dec 3-17; 153(11-12):742. PubMed ID: 2247007
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pros and cons of methadone?].
    Lôo H; Laqueille X
    Rev Prat; 2002 Oct; 52(15):1629-30. PubMed ID: 12434589
    [No Abstract]   [Full Text] [Related]  

  • 12. Extensive cutaneous fibrosis and ulceration caused by methadone injection.
    Farrant P; Creamer D; Fuller C
    Clin Exp Dermatol; 2005 Jan; 30(1):87-8. PubMed ID: 15663513
    [No Abstract]   [Full Text] [Related]  

  • 13. [Depressive disorders in management of drug dependent patients. Methadone maintenance].
    Laqueille X; Spadone C
    Encephale; 1995 Dec; 21 Spec No 4():11-4. PubMed ID: 8808339
    [No Abstract]   [Full Text] [Related]  

  • 14. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone maintenance: an update.
    Senay EC
    NIDA Res Monogr; 1983 Apr; 43():51-8. PubMed ID: 6410279
    [No Abstract]   [Full Text] [Related]  

  • 16. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of methadone treatment on cardiac repolarization and conduction in opioid users.
    Martell BA; Arnsten JH; Krantz MJ; Gourevitch MN
    Am J Cardiol; 2005 Apr; 95(7):915-8. PubMed ID: 15781034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug substitution with methadone--contra arguments].
    Lux F
    Offentl Gesundheitswes; 1988; 50(8-9):533-8. PubMed ID: 2972974
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
    Anchersen K; Clausen T; Gossop M; Hansteen V; Waal H
    Addiction; 2009 Jun; 104(6):993-9. PubMed ID: 19392907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
    Jagsch R; Gombas W; Schindler SD; Eder H; Moody DE; Fischer G
    Addict Biol; 2005 Dec; 10(4):365-71. PubMed ID: 16318959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.